Thus, the strengths of Gupta and colleagues» study lie in the fact that these were the same patients, no run - in period existed to exclude patients intolerant to therapy, and few patients had
previously taken any statins.
This new study suggests that the risk of developing type 2 diabetes is somewhat higher than
previously estimated — however the study was not specifically designed to address this issue, and it relies on modelling to
take into account confounding factors underlying the reasons for prescribing
statins.